Elekta AB (publ) (EKTAY)
USD 5.45
(-0.55%)
USD 5.45
(-0.55%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 4.8 Billion SEK | -15.76% |
| 2023 | 6.41 Billion SEK | 29.92% |
| 2022 | 4.94 Billion SEK | 26.76% |
| 2021 | 3.89 Billion SEK | -52.15% |
| 2020 | 8.14 Billion SEK | 128.89% |
| 2019 | 3.55 Billion SEK | -18.56% |
| 2018 | 4.36 Billion SEK | -17.13% |
| 2017 | 5.27 Billion SEK | 72.01% |
| 2016 | 3.06 Billion SEK | -38.18% |
| 2015 | 4.95 Billion SEK | 13.69% |
| 2014 | 4.36 Billion SEK | 0.48% |
| 2013 | 4.34 Billion SEK | -1.74% |
| 2012 | 4.41 Billion SEK | 464.83% |
| 2011 | 782 Million SEK | -16.54% |
| 2010 | 937 Million SEK | -37.86% |
| 2009 | 1.5 Billion SEK | 6.5% |
| 2008 | 1.41 Billion SEK | 68.57% |
| 2007 | 840 Million SEK | -19.92% |
| 2006 | 1.04 Billion SEK | 32.95% |
| 2005 | 789 Million SEK | 0.0% |
| 2004 | - SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| 2002 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 6.61 Billion SEK | 0.22% |
| 2024 Q3 | 5.73 Billion SEK | -1.0% |
| 2024 Q4 | 4.8 Billion SEK | -16.23% |
| 2024 FY | 4.8 Billion SEK | -25.1% |
| 2024 Q1 | 6.51 Billion SEK | 1.35% |
| 2023 Q3 | 4.88 Billion SEK | -0.83% |
| 2023 Q1 | 4.91 Billion SEK | -0.43% |
| 2023 Q4 | 6.41 Billion SEK | 31.49% |
| 2023 FY | 6.41 Billion SEK | 29.92% |
| 2023 Q2 | 4.92 Billion SEK | 0.06% |
| 2022 Q3 | 5.5 Billion SEK | 41.11% |
| 2022 Q1 | 3.9 Billion SEK | 0.08% |
| 2022 Q2 | 3.89 Billion SEK | -0.03% |
| 2022 FY | 4.94 Billion SEK | 26.76% |
| 2022 Q4 | 4.94 Billion SEK | -10.21% |
| 2021 FY | 3.89 Billion SEK | -52.15% |
| 2021 Q4 | 3.89 Billion SEK | -32.8% |
| 2021 Q3 | 5.79 Billion SEK | -1.56% |
| 2021 Q1 | 7.85 Billion SEK | -3.5% |
| 2021 Q2 | 5.89 Billion SEK | -25.04% |
| 2020 FY | 8.14 Billion SEK | 128.89% |
| 2020 Q3 | 3.66 Billion SEK | -12.31% |
| 2020 Q4 | 8.14 Billion SEK | 122.45% |
| 2020 Q2 | 4.17 Billion SEK | -8.26% |
| 2020 Q1 | 4.55 Billion SEK | 27.91% |
| 2019 Q1 | 4.34 Billion SEK | -0.64% |
| 2019 FY | 3.55 Billion SEK | -18.56% |
| 2019 Q4 | 3.55 Billion SEK | -20.28% |
| 2019 Q2 | 4.42 Billion SEK | 1.87% |
| 2019 Q3 | 4.46 Billion SEK | 0.93% |
| 2018 Q1 | 4.65 Billion SEK | -11.8% |
| 2018 Q2 | 4.72 Billion SEK | 1.63% |
| 2018 Q3 | 4.18 Billion SEK | -11.55% |
| 2018 FY | 4.36 Billion SEK | -17.13% |
| 2018 Q4 | 4.36 Billion SEK | 4.52% |
| 2017 Q1 | 3.2 Billion SEK | 4.44% |
| 2017 Q4 | 5.27 Billion SEK | 63.02% |
| 2017 Q3 | 3.23 Billion SEK | -1.7% |
| 2017 Q2 | 3.29 Billion SEK | 2.78% |
| 2017 FY | 5.27 Billion SEK | 72.01% |
| 2016 Q4 | 3.06 Billion SEK | -39.08% |
| 2016 Q1 | 5.04 Billion SEK | 1.8% |
| 2016 FY | 3.06 Billion SEK | -38.18% |
| 2016 Q2 | 5.02 Billion SEK | -0.46% |
| 2016 Q3 | 5.03 Billion SEK | 0.14% |
| 2015 Q3 | 3.96 Billion SEK | 6.82% |
| 2015 Q4 | 4.95 Billion SEK | 25.17% |
| 2015 Q2 | 3.7 Billion SEK | -17.01% |
| 2015 Q1 | 4.46 Billion SEK | 2.45% |
| 2015 FY | 4.95 Billion SEK | 13.69% |
| 2014 Q3 | 4.34 Billion SEK | 0.91% |
| 2014 Q4 | 4.36 Billion SEK | 0.46% |
| 2014 Q2 | 4.3 Billion SEK | -1.01% |
| 2014 Q1 | 4.34 Billion SEK | 0.14% |
| 2014 FY | 4.36 Billion SEK | 0.48% |
| 2013 Q4 | 4.34 Billion SEK | 1.71% |
| 2013 FY | 4.34 Billion SEK | -1.74% |
| 2013 Q3 | 4.26 Billion SEK | -2.38% |
| 2013 Q2 | 4.37 Billion SEK | -1.35% |
| 2013 Q1 | 4.43 Billion SEK | 0.32% |
| 2012 Q4 | 4.41 Billion SEK | 68.14% |
| 2012 FY | 4.41 Billion SEK | 464.83% |
| 2012 Q1 | 2.1 Billion SEK | 169.69% |
| 2012 Q2 | 2.12 Billion SEK | 0.71% |
| 2012 Q3 | 2.62 Billion SEK | 23.68% |
| 2011 Q4 | 782 Million SEK | -8.11% |
| 2011 Q1 | - SEK | -100.0% |
| 2011 Q2 | 894 Million SEK | 0.0% |
| 2011 Q3 | 851 Million SEK | -4.81% |
| 2011 FY | 782 Million SEK | -16.54% |
| 2010 FY | 937 Million SEK | -37.86% |
| 2010 Q4 | 937 Million SEK | 0.0% |
| 2009 FY | 1.5 Billion SEK | 6.5% |
| 2008 FY | 1.41 Billion SEK | 68.57% |
| 2007 FY | 840 Million SEK | -19.92% |
| 2006 FY | 1.04 Billion SEK | 32.95% |
| 2005 FY | 789 Million SEK | 0.0% |
| 2004 FY | - SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| 2002 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | -581.576% |
| Ansell Limited | 706.6 Million USD | -580.3% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -21348.749% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -769020.0% |
| ConvaTec Group Plc | 1.22 Billion USD | -292.354% |
| ConvaTec Group Plc | 1.22 Billion USD | -291.8% |
| Encision Inc. | 67.33 Thousand USD | -7138726.185% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -1255525.762% |
| LifePoint, Inc. | 151.73 Thousand USD | -3167944.077% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -97722.548% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -781526.016% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -2671004.616% |
| SmileDirectClub, Inc. | 849.37 Million USD | -465.943% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -2180.578% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -9913488.649% |
| Vasamed, Inc. | 18.95 Thousand USD | -25366654.617% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -26028706.584% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -1231059.318% |